Mitsuru Hashida

23.9k citations
540 papers · 21.2k · h-index 78

Impact in

    • Advanced Drug Delivery Systems
    • Advancements in Transdermal Drug Delivery
    • Drug Solubulity and Delivery Systems
  • Biomaterials top 0.05%
    • Nanoparticle-Based Drug Delivery

Papers in

    • Advanced Drug Delivery Systems 98
    • Advancements in Transdermal Drug Delivery 39
    • Drug Solubulity and Delivery Systems 37
    • Nanoparticle-Based Drug Delivery 180

Mitsuru Hashida

534 papers receiving 20.2k citations

Peers

Mitsuru Hashida
Comparison fields: 5 of 149
  • Pharmaceutical Science 3.9k
  • Biomaterials 6k
  • Molecular Biology 7.5k
  • Drug Discovery 24
  • Immunology 1.1k
Replace Yoshinobu Takakura with:
Yoshinobu Takakura Japan
Hideyoshi Harashima Japan
Qiang Zhang China
Arto O. Urtti Finland
Fumiyoshi Yamashita Japan
Zhirong Zhang China
Jianqing Gao China
Crispin R. Dass Australia
Hiroshi Maeda Japan
Francesco Maria Veronese Italy
Mitsuru Hashida relative to Yoshinobu Takakura Japan Yoshinobu Takakura's profile →
Citations per field
00.5×2×3×
Yoshinobu Takakura · 1×
Citations per year

Countries citing papers authored by Mitsuru Hashida

Since Specialization
Citations

This map shows the geographic impact of Mitsuru Hashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuru Hashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuru Hashida more than expected).

Fields of papers citing papers by Mitsuru Hashida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuru Hashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuru Hashida. The network helps show where Mitsuru Hashida may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitsuru Hashida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitsuru Hashida Line = papers co-authored together Mitsuru Hashida links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 540 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1995398
2 1995322
3 1998254
4 2000250
5 2012243
6 2000229
7 1990206
8 1996195
9 2004181
10 2009175
11 2012170
12 1987168
13 2012168
14 2006164
15 2000155
16 2001155
17 2001153
18 2003150
19 2000145
20 1998141

About Mitsuru Hashida

Mitsuru Hashida is a scholar working on Pharmaceutical Science, Biomaterials, Molecular Biology, Immunology and Oncology, having authored 540 papers that have together received 21.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (180 papers), RNA Interference and Gene Delivery (146 papers), Advanced Drug Delivery Systems (98 papers), Drug Transport and Resistance Mechanisms (40 papers), Advancements in Transdermal Drug Delivery (39 papers), Drug Solubulity and Delivery Systems (37 papers), Computational Drug Discovery Methods (22 papers) and Redox biology and oxidative stress (21 papers). The work is most often cited by research in Pharmaceutical Science (3.9k citations), Biomaterials (6k citations), Molecular Biology (7.5k citations), Drug Discovery (24 citations) and Immunology (1.1k citations). Mitsuru Hashida has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Fumiyoshi Yamashita, Yoshinobu Takakura, Shigeru Kawakami, Makiya Nishikawa, Hitoshi Sezaki, Hitoshi Sezaki, Yuriko Higuchi, Ram I. Mahato, Kenji Kawabata and Yoshinobu Takakura. Their work appears in journals such as Journal of Controlled Release, Pharmaceutical Research, International Journal of Pharmaceutics, Biological and Pharmaceutical Bulletin and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact